Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fat injection with or without stromal vascular fraction for facial wrinkles
IRCT20140705018373N4Phase 3Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Sep 2020
- Modality
- Stem Cell Therapies → Cell Therapies, Cell Therapies
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of autologous fat tissue and autologous adipose stromal vascular fraction in rhytides (2 arms), sponsored by Tabriz University of Medical Sciences. Primary endpoint: Severity of nasolabial and cheek wrinkles at 12 months. Started Sep 2020; status: completed.
02
Drugs
autologous fat tissueautologous adipose stromal vascular fraction
03
Conditions
rhytides
Beyond the preview
Go deeper on IRCT20140705018373N4.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20140705018373N4.